Stock Price
3.77
Daily Change
1.21%
Yearly
-85.19%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Daiichi Sankyo 2,594.50 27.50 1.07% -28.11%
AbbVie 133.00 -2.21 -1.63% 19.54%
Adamas Pharmaceuticals 8.22 0.06 0.74% 91.16%
Alnylam Pharmaceuticals 138.49 -0.13 -0.09% -16.95%
Alexion Pharmaceuticals 182.50 0 0% 70.54%
Amgen 228.90 -2.40 -1.04% -9.18%
Amarin 3.21 -0.10 -2.88% -49.13%
Arena Pharmaceuticals 91.15 -0.36 -0.39% 12.23%
Biogen 225.91 -4.93 -2.14% -16.37%
BioMarin Pharmaceutical 86.50 0.50 0.58% -0.44%
Cytokinetics 30.81 -0.89 -2.81% 53.36%
Esperion Therapeutics 3.77 0.05 1.21% -85.19%
Flexion Therapeutics 9.12 -0.02 -0.22% -17.76%
Geron 1.08 -0.03 -2.27% -35.33%
Halozyme Therapeutics 33.56 -0.20 -0.58% -29.35%
Heron Therapeutics 8.53 0.14 1.61% -51.56%
Intercept Pharmaceuticals 17.00 -0.44 -2.49% -39.46%
Ionis Pharmaceuticals 30.01 -0.31 -1.02% -52.01%
Intra Cellular Therapies 38.87 0.08 0.21% 18.92%
Eli Lilly 243.10 -2.30 -0.94% 20.14%
Merck & Co 80.73 -0.56 -0.68% -0.55%
Moderna Inc 167.52 -7.16 -4.11% 25.97%
Minerva Neurosciences 0.82 0.003 0.34% -74.29%
Nektar Therapeutics 11.78 -0.34 -2.76% -29.29%
Puma Biotechnology 2.52 -0.07 -2.50% -76.23%
Pfizer 54.05 0.48 0.90% 48.16%
PTC Therapeutics 40.07 -0.94 -2.28% -36.45%
Regeneron Pharmaceuticals 614.38 -3.60 -0.58% 14.73%
Sanofi 92.95 1.22 1.33% 14.16%
Seattle Genetics 133.06 0.51 0.38% -28.38%
Sarepta Therapeutics 64.59 1.49 2.36% -33.36%
United Therapeutics 199.97 -5.10 -2.49% 19.64%
Vanda Pharmaceuticals 13.91 0.02 0.11% -4.40%
Acceleron Pharma 178.75 -0.93 -0.52% 57.43%
Zogenix 26.00 0.08 0.31% 41.77%

Indexes Price Day Year
NASDAQ 14154 -186.23 -1.30% 4.61%
US2000 2024 -38.75 -1.88% -5.48%

Esperion Therapeutics
Esperion Therapeutics, Inc. is a lipid management company. The Company is a pharmaceutical company focused on developing and commercializing oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol (LDL-C). Its bempedoic acid and the bempedoic acid / ezetimibe combination tablets are oral, once-daily, non-statin, LDL-C lowering medicines for patients with atherosclerotic cardiovascular disease (ASCVD), or heterozygous familial hypercholesterolemia (HeFH). Its products include NEXLETOL, NILEMDO, NEXLIZET and NUSTENDI. NEXLETOL and NILEMDO are ATP Citrate Lyase (ACL) inhibitor that lowers LDL-C by reducing cholesterol biosynthesis and up-regulating the LDL receptors. NEXLIZET and NUSTENDI contains bempedoic acid and ezetimibe and lowers elevated LDL-C through complementary mechanisms of action by inhibiting cholesterol synthesis in the liver and absorption in the intestine.